New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests:
Grelan Pharmaceuticals Ltd.
Division of ASKA Pharmaceutical Co. Ltd.
Latest From Grelan Pharmaceuticals Ltd.
Fournier's European Strategy
To reduce its dependence on a stagnant and price sensitive French market, Fournier has created a low-risk R&D program coupled with an aggressive international acquisition program. The program attempts to take advantage of small-market research opportunities as well as acquisition targets overlooked by large companies or which fall out of mega-mergers. Is this gamble enough to ensure independence for a mid-sized player?
Company Information
- Industry
- Pharmaceuticals
- Therapeutic Areas
- Non-Specific
- Alias(es)
- Ownership
- Headquarters
-
Worldwide
-
Asia
-
Pacific Rim
-
Japan
-
Japan
-
Pacific Rim
-
Asia
- Parent & Subsidiaries
- ASKA Pharmaceutical Co. Ltd.
- Senior Management
- Akira Yanagisawa, Pres. & CEO
- Contact Info
-
Grelan Pharmaceuticals Ltd.
Phone: (81) 3 3281 1451
3-14-1 Nihonbashi, Chuo-ku
Tokyo, 103
Japan
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Grelan Pharmaceuticals Ltd.
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice